BCHE and amyloidosis: Cholinergic dysfunction is a hallmark of Alzheimer's disease (AD), driven by elevated acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activity that depletes acetylcholine and contributes to amyloid pathology.